Potential Immunological Treatments in COVID-19 Patients

Basit Öğe Kaydı
dc.contributor.authorÖzdemir, Öner
dc.contributor.authorEngin, Muhammet Mesut Nezir
dc.date.accessioned2023-04-10T20:19:34Z
dc.date.available2023-04-10T20:19:34Z
dc.date.issued2021
dc.departmentRektörlük, Rektörlüğe Bağlı Birimler, Düzce Üniversitesi Dergilerien_US
dc.description.abstractDecember 2019. SARS-CoV-2 infection in human was named as coronavirus disease 2019(COVID-19). It has now infected more than 69 million people worldwide, becoming anepidemic responsible for more than 1,5 million deaths until 10th of December 2020. Theepidemic still continues. This epidemic is the third epidemic caused by coronaviruses in the21st century and may be the most important infectious disease representing a major publichealth threat to the whole world. Treatments against COVID-19 are constantly updated in theliterature, based on evidence. Unfortunately, there is no definitive cure for COVID-19, and anumber of drugs for use in severe cases of COVID-19 are now being studied in a number ofnonrandomized or randomized trials. These include chloroquine, steroids, anti-inflammatory,and antiviral agents. Immunological treatments such as convalescent plasma, intravenousimmunoglobulin, monoclonal antibodies (tocilizumab, eculizumab, itolizumab etc.), andanakinra treatments are tried in COVID-19 disease. Results from some trials look promising.Quite a few reports have also stood published so far on the use of immunological treatmentsfor COVID-19 cases. In this review, we will discuss the key immunological treatments, mostlymentioned in the current literature, used in COVID-19 patients in detail.en_US
dc.identifier.doi10.18678/dtfd.856165
dc.identifier.endpage9en_US
dc.identifier.issn1307-671X
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.trdizinid421855en_US
dc.identifier.urihttp://doi.org/10.18678/dtfd.856165
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/421855
dc.identifier.urihttps://hdl.handle.net/20.500.12684/11415
dc.identifier.volume23en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlePotential Immunological Treatments in COVID-19 Patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11415.pdf
Boyut:
525.62 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Düzce Tıp Fakültesi Dergisi Koleksiyonu